BIOKÉ and Bethyl Laboratories, Inc. Announce a Distribution Agreement for The BeNeLux countries

/in , , , /by

LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe (CST Europe), and Bethyl Laboratories, Inc. announced that they have signed an agreement allowing BIOKÉ to exclusively distribute Bethyl’s products in the BeNeLux countries (Netherlands, Belgium, Luxembourg), effective immediately. Bethyl Laboratories is dedicated to supporting scientific discovery through its qualified polyclonal and recombinant rabbit monoclonal […]

Read more →

Strand Life Sciences Creates Another Global Bioinformatics Landmark With Strand Ramanujan

/in , , , /by

Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark Bangalore, India Strand Life Sciences today announced the release of version 3.0 of its flagship, next-generation sequencing (NGS) data analysis and visualization platform, Strand NGS. Benchmarked against the world’s best, major enhancements in this release have led to significant improvements […]

Read more →

IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay

/in , , , /by

MENLO PARK, Calif.–IncellDx, Inc. announces the release of their CE marked OncoTect iO® Lung Kit today, March 30, 2017, entering the immunotherapeutic diagnostic market in Europe and countries that accept the CE- mark and declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC for registration of in vitro diagnostic devices. The OncoTect […]

Read more →

New Research Innovations in Liquid Biopsy, Bioinformatics and Liquid Handling Advance Future of Precision Medicine

/in , , , , , /by

Broad spectrum of technological advances for cancer research on display at AACR 2017 WASHINGTON, D.C.–AACR 2017 – Thermo Fisher Scientific, the world leader in serving science, will highlight its latest innovative solutions for research designed to help customers advance the future of precision medicine. The new products and a wide spectrum of scientific posters will […]

Read more →

FlowJo, LLC Launches SeqGeqTM for Single-Cell NGS Data Analysis

/in , , , /by

ASHLAND, Ore. FlowJo, LLC, a bioinformatics and data analysis company with 19+ years experience in software for analyzing single-cell data, launched SeqGeq today, a desktop application that gives bench scientists the ability to quickly and efficiently analyze single-cell omics data. SeqGeq offers a powerful set of tools that help researchers rapidly identify subpopulations of cells […]

Read more →

Agilent Technologies Showcases Cancer Research Innovations at AACR 2017

/in , , , , /by

Focus on Technological Advances in Genomics and Cellular Analysis SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced it will showcase some of its most recent technological advances in the areas of cell analysis and genomics at the AACR Annual Meeting 2017, being held April 1 – 5, 2017 in Washington, D.C. Agilent will […]

Read more →

SCIEX Announces New Biotransformation Solutions for Routine and Comprehensive Metabolism and Biologic Catabolism Studies

/in , , , , , /by

Biotransform solutions use the first commercial software to automate protein catabolite identification and speeds identification of metabolites and catabolites. FRAMINGHAM, Mass.–SCIEX, a global leader in life science analytical technologies, announced today the latest additions to its growing line of solutions for pharmaceutical drug discovery and development. The Routine Biotransform Solution and the Advanced Biotransform Solution […]

Read more →

NanoString Launches Multiple New Products at AACR 2017 to Advance Precision Oncology Research

/in , , /by

New Offerings Include nCounter Platform Enhancements as Well as New Panels That Expand NanoString’s Footprint in Immuno-oncology and 3D Biology Research SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, is releasing multiple new products at the American Association of Cancer Research (AACR) Meeting. The new products build […]

Read more →

CARL R. WOESE INSTITUTE FOR GENOMIC BIOLOGY, UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN A new agreement between the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign and ZEISS has named the Core Facilities at IGB as an official ZEISS labs@location Partner. The model facility will allow researchers from around the U.S. to test-drive new instruments in the IGB’s Core Facilities Microscopy Suite. This partnership represents the first North American location of the ZEISS labs@location partner program, already in use across Europe. “With this special partnership with IGB Core Facilities, we transfer a successful labs@location program from Europe to the U.S.,” said Jim Sharp, President Carl Zeiss Microscopy LLC. “labs@location is a community of our ZEISS customers and partners providing in depth knowledge and dedicated services. We are very excited that the IGB becomes our first American ZEISS labs@location.” The agreement will allow IGB and Illinois researchers access to select cutting edge technologies immediately following–or in some cases before–their broad release. New instruments, on loan from ZEISS, will cycle through the Core and be available to all users during that time. In addition, the agreement provides for training and classes taught by ZEISS personnel at the IGB that will better position Core staff and researchers to best utilize new equipment. ZEISS instrument specialists will provide instruction and instrument demos to Illinois and visiting scientists, as well as assist in training the IGB Core staff to provide similar instruction themselves. “ZEISS training is really valuable,” said Core Facilities Director Glenn Fried, “but until now, you’ve had to send your people to the ZEISS Microscopy Customer Center in New York twice a year to see that benefit. Now all of my staff, as well as graduate students, postdocs, and faculty, can come to those classes at the IGB.” Fried anticipates that one of the first new instruments under the agreement will be a ZEISS Celldiscoverer 7, a new automated microscopy platform for high throughput live cell imaging. Though the IGB has equipment for that purpose, Fried says that the ZEISS Celldiscoverer 7 offers improved clarity and visibility, allowing for sharper and more accurate images. “This is a really exciting thing for the Core, and for everyone who uses our instruments,” said Fried. “Researchers will have access to the newest technology–like ZEISS Celldiscoverer–long before they would if we had to write a grant or even just went out and bought it.” In all, the ZEISS partnership promises to establish itself as a regional center of excellence in biological imaging by attracting researchers from around the country to demo new instruments and attend trainings. “We are thrilled to partner with ZEISS in this way, because it will enhance the research capabilities of scientists studying many different types of questions, thus enabling the IGB to provide an important new benefit to the campus. Being selected by ZEISS to be the first labs@location in North America is a great honor, and a recognition of the excellence of our Core Facilities and especially the entire Core Facilities staff,” said IGB Director Gene Robinson.

/in , , /by

MOUNTAIN VIEW, Calif. — Cellecta, Inc. today announced the launch of the Driver-Map™ Human Genome-Wide Gene Expression Profiling kit, a targeted RNA expression profiling assay designed to easily provide a molecular snapshot of all known 19,000 human protein-coding genes from complex samples starting from as little as 10 pg of total RNA. The multiplex RT-PCR-based, followed […]

Read more →